Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
9Q9C55FRqGNNwQMN
Listen
